ask="17.50"
ask_size="10000"
average_daily_volume="151541"
bid="15.12"
bid_size="1000"
book_value="6.55"
change="+0.03"
change_from_200_day_moving_average="1.31"
change_from_50_day_moving_average="0.53"
change_from_52_week_high="-9.33"
change_From_52_week_low="4.72"
change_in_percent="+0.18%"
close="16.74"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.68"
ebitda="-63.46M"
eps_estimate_current_year="-3.02"
eps_estimate_next_quarter="-0.73"
eps_estimate_next_year="-3.05"
ex_dividend_date="N/A"
float_shares="11787000"
high="16.92"
high_52_weeks="26.07"
last_trade_date="1/12/2017"
last_trade_price="16.74"
last_trade_size="100"
last_trade_time="3:59pm"
low="16.32"
low_52_weeks="12.02"
market_capitalization="367.98M"
moving_average_200_day="15.43"
moving_average_50_day="16.21"
name="Adamas Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="34.13"
open="16.56"
pe_ratio="N/A"
peg_ratio="-0.07"
percent_change_from_200_day_moving_average="+8.51%"
percent_change_from_50_day_moving_average="+3.30%"
percent_change_from_52_week_high="-35.79%"
percent_change_from_52_week_low="+39.27%"
previous_close="16.71"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.55"
price_per_sales="346.85"
revenue="1.06M"
shares_outstanding="21982000"
short_ratio="29.71"
stock_exchange="NGM"
symbol="ADMS"
volume="126983"
weeks_range_52="12.02 - 26.07"
